SciBite - From Molecule To Merger  

Page 1 of 2 © 2013 SciBite Limited. Registered In England & Wales No. 7778456 Contact us via http://scibite.com/talk.html http://about.scibite.com @Scibitely

PHARMA & BIOTECH INTELLIGENCE SOLUTIONS Understanding The Therapeutic Landscape

SciBite provides a powerful new approach to competitor intelligence and opportunity spotting within drug discovery. Our combination of advanced semantic text analysis and crowd-sourced, community trends provides you with a unique perspective on drugs, companies, targets and indications across patents, papers, clinical trials, grants, news and social media. All of this is live, updated continuously – you’ll never miss the next big thing! SciBite is essentially a large database of every recent article of relevance to drug discovery, accurately tagged with critical concepts. The system excels at: ¤ INFORMING SCIENTISTS & BUSINESS ANALYSTS

SCIBITE.COM: Live Pharma Intelligence SCIBITE-PLUS: Coming Soon! Keep up to date with the latest Drug Discovery trends. Literature, Patents, Grants, Clinical Trials, Blogs, News, Tweets and more, all in one place!

Cutting-edge analytics to provide deep insight into new therapeutic opportunities and competitor activity. All from a single, web-based dashboard

¤ ENABLING INFORMATICIANS AND DATA MINERS

THE SCIBITE API “TERMITE” – TEXT MINING TOOL Access all of our data for your own data mining. Find and mine new connections between drugs, companies, targets and indications.

Class-leading text-mining software and entity recogniser. Semantic markup of documents and improve search engine performance. Best in class thesauri.

¤ ENHANCING YOUR INTERNAL INFORMATION SYSTEMS

SCIBITE WIDGETS SCIBITE DATA Embed live news into your own applications, provide your scientists with instant, relevant updates. Simple, standards-based integration.

Access the full SciBite dataset and connect the rich information on the drug discovery landscape into your internal network

Contact us today to discuss how your organisation can keep track of new developments for the therapy areas and targets you care about. Take a look at: http://scibite.com. To contact us, please visit: http://scibite.com/talk.html

  SciBite - From Molecule To Merger  

Page 2 of 2 © 2013 SciBite Limited. Registered In England & Wales No. 7778456 Contact us via http://scibite.com/talk.html http://about.scibite.com @Scibitely

Publications/year for breast cancer targets

Time

Target

¤ SOURCES - SCANNED EVERY MINUTE, EVERY DAY No other system provides as broad coverage, in real time!

Name Description MEDLINE Broad coverage of the biomedical published literature CLINICALTRIALS.GOV Clinical trials database from the US NIH ISRCTN World-wide clinical trials database EUCTR European clinical trials register PATENTS WO, EP and US office life science and clinical patents GRANTS New grant awards in the US from the NIH NEWS Latest stories from thousands of government, industry and media websites SOCIAL Latest blog posts and tweets from key figures in the industry REAGENTS Biologically relevant chemicals ¤ MAJOR ENTITIES (CONCEPTS) COVERED Code Description Links To Public IDs? GENE Human gene/proteins Yes (HGNC) PROTYP Protein Types (Families) Yes (HGNC) INDICATION Human disease/indication Yes (MeSH) COMPANY Pharma/Biotech companies No (SciBite Proprietary) DRUG Known drugs (clinical, development & discovery) Yes (ChEMBL) MIRNA MicroRNAs Yes (mirBase) MUTATION Protein Mutations No (Not applicable) RESCODE Drug research codes Yes (ChEMBL) BIOCHEM Biologically relevant chemicals Yes (MeSH) We use extensive synonym collections (‘thesauri”) to scan every article we see for mentions of critical drug discovery topics. Many of these are based on public sources, designed to facilitate integration with other data. However, they are extensively curated and validated to compensate for the many missing or ambiguous terms found in raw sources. Our Protein Family collection covers high-level molecule groups (such as ‘Interleukins’, ‘Cytokines’, ‘DNA Methylases’) capturing far more than traditional gene-centric approaches. We believe our thesauri give us, and potentially you, a clear advantage. ¤ WHAT CAN I DO WITH IT ALL? Our unparalleled combination of data mining and crowd-sourced social trends results in a powerful dataset for understanding the latest “hot” areas in drug discovery. By viewing our data in different ways you can understand competitor activity, look for new targets for an indication, find new biomarkers or biological approaches, monitor drug failures, identify trends and much more. Here are just some of the many ways to view our data:

ABOUT SCIBITE SciBite is led by scientists with many years experience analysing and acting on competitor intelligence within big pharma. We believe that our unique approach opens up access to this type of data to a wider audience and provides new opportunities to understand the ever-changing therapeutic landscape.

Trend Plots pick out topics peaking in activity

Heat maps differentiate novel and precedented approaches

GEO tagging shows who’s working on what, and where.